Molecular and functional characterization of gene variants, identified by whole genome association studies, involved in the regulation of fetal hemoglobin levels and in the clinical amelioration of the β-thalassemia and other hemoglobinopathies phenotype. In particular, this project aims to clarify the mechanism of action of the BCL11A transcription factor, with the goal of developing new therapeutic treatments for hereditary anemias.